Skip to main content

Table 1 Patient characteristics

From: The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson’s disease

 

German chronic cohort

(n = 147)

US ALF cohort

(n = 28)

Age at blood sample collection (years)

35 (16–69)

26 (15–57)

Female gender

79 (54%)

20 (71%)

ALT (U/L)

36 (10–436)

36 (7–1463)

AST (U/L)

30 (8–580)

188 (43–4481)

GGT (U/L)

33 (5–471)

Bilirubin (mg/dL)

0.7 (0.3–7.8)

31.4 (4.5–67.6)

Albumin (g/L)

44 (22–53)

24 (16–28)

Urea (kU/L)

6.1 (1.0–11.9)

Sodium (mmol/L)

139 (131–149)

Creatinine (mg/dL)

0.7 (0.4–2.4)

1.2 (0.4–7.1)

WBC count (× 109/L)

5.9 (2.5–12.8)

13.4 (3.4–54.9)

INR

1.1 (0.9–2.0)

2.8 (1.7–6.5)

Phosphate (mmol/dL)

2.9 (1.0–11.7)

Serum copper (μmol/L)

4.5 (0.1–29.9)

0.3 (0.2–208.0)

Ceruloplasmin (g/L)

0.10 (0.01–0.32)

0.17 (0.04–0.45)

Urinary copper (μmol/day)†, ‡

2.5 (0.2–27.5)

40,110.2 (661.4–9,931,842.2)

  1. ALT alanine aminotransferase, AST aspartate aminotransferase, GGT gamma-glutamyltransferase, WBC white blood cell, INR international normalized ratio
  2. Values are obtained at the same time as the blood samples used to measure soluble CD163
  3. Data are medians (ranges) for continuous variables and total number (%) for categorical variables
  4. n = 17 in US ALF cohort
  5. n = 108 in German chronic cohort